IMPM secures a 2024 Schistosomiasis Research Grant from Merck Group
The Institute of Medical Research and Studies of Medicinal Plants (IMPM) in Cameroon has been selected as winner of one of the prestigious Schistosomiasis Research Grant 2024, supported by the Merck Group.
Continue Reading